Article
Citigroup Maintains Buy on Sotera Health, Raises Price Target to $23
Citigroup analyst Patrick Donnelly maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $21 to $23.
Comments
- No comments yet. Be the first to comment!